Tamer Khayal
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Tamer I.
Khayal is Chief Medical Officer at TransMedics, Inc. since 2013 and Senior Vice President-International at TransMedics Group, Inc. starting in 2026.
Formerly, Dr. Khayal was Director-Clinical Affairs at Zentiva Group.
Education includes a doctorate from KasrAlAiny School of Medicine conferred in 1993.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 15 038 ( 0,04% ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TRANSMEDICS GROUP, INC. | Corporate Officer/Principal | 01/01/2018 |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Directeur Technique/Scientifique/R&D | 01/05/2001 |
| Sociétés | Poste | Fin |
|---|---|---|
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Health Technology |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
KasrAlAiny School of Medicine
KasrAlAiny School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics Group, Inc.
TransMedics Group, Inc. Medical SpecialtiesHealth Technology Manufactures portable electromechanical medical devices for organ transplantation of end-stage organ failure patients | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national